Abstract
Objectives
To assess the effects of a combination of omega 3 essential fatty acids, green tea catechins, and ginsenosides on cognition and brain functioning in healthy older adults.
Design
Double-blind, placebo-controlled, crossover design randomized controlled trial with 26-day intervention phases and a 30-day washout period.
Setting
The Institute for Dementia Research and Prevention at the Pennington Biomedical Research Center.
Participants
Ten independently-living, cognitively-healthy older adults (mean age: 67.3 + 2.01 years). Intervention: Daily consumption of an investigational product (trade name “Cerbella TM”) consisting of an emulsified liquid combination of standardized fish oil, panax ginseng extract, and green tea catechins in a flavored base of lecithin phospholipids optimized to maximize bioavailability of the active ingredients.
Measurements
Before and after supplementation with the investigational product or placebo, participants completed cognitive tests including the Mini Mental State Exam (MMSE), Stroop test, Digit Symbol Substitution Test (DSST), and Immediate and Delayed Recall tests, as well as functional magnetic resonance imaging (fMRI) during a standard cognitive task switching paradigm.
Results
Performance on the MMSE, Stroop test, and DSST increased significantly over one month of supplementation with the investigational product (one-sample t tests, p<.05) although differences between these changes and corresponding changes during supplementation with placebo were not significant (two-sample t tests, p>.05). During supplementation with the investigational product, brain activation during task performance increased significantly more than during supplementation with placebo in brain regions known to be activated by this task (anterior and posterior cingulate cortex). Functional connectivity during task execution between task regions (middle frontal gyrus and anterior cingulate cortex) increased significantly during supplementation with the investigational product, relative to placebo. Functional connectivity during rest between task regions (precentral gyrus and middle frontal gyrus) and default mode network regions (medial frontal gyrus and precuneus) decreased during supplementation with the investigational product relative to placebo, suggesting greater segregation of task and rest related brain activity.
Conclusion
One-month supplementation with a combination of omega 3 essential fatty acids, green tea catechins, and ginsenosides was associated with suggestive changes in cognitive functioning as well as modification of brain activation and brain functional connectivity in cognitively healthy older adults.
Similar content being viewed by others
References
Moore, K.E. and J.E. Brennan. ALPHA/Sim simulation software tutorial. in Proceedings of the 28th conference on Winter simulation. 1996. IEEE Computer Society.
Mather, M., Fact Sheet: Aging in the United States. Population Reference Bureau, 2016.
Kriegeskorte, N., et al., Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci, 2009. 12(5): p. 535–40.
Dirnagl, U., C. Iadecola, and M.A. Moskowitz, Pathobiology of ischaemic stroke: an integrated view. Trends in Neurosciences, 1999. 22(9): p. 391–397.
Bejot, Y., et al., Trends in Incidence, Risk Factors, and Survival in Symptomatic Lacunar Stroke in Dijon, France, From 1989 to 2006 A Population-Based Study. Stroke, 2008. 39: p. 1945–1951.
Hebert, L.E., et al., Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census. Arch Neurol, 2003. 60(8): p. 1119–1122.
Tilvis, R.S., et al., Predictors of cognitive decline and mortality of aged people over a 10-year period. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2004. 59(3): p. M268–M274.
Wimo, A., et al., The worldwide economic impact of dementia 2010. Alzheimer’s & Dementia, 2013. 9(1): p. 1–11. e3.
Ravina, B., et al., Neuroprotective agents for clinical trials in Parkinson’s disease A systematic assessment. Neurology, 2003. 60(8): p. 1234–1240.
Scapagnini, G., et al., Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Molecular neurobiology, 2011. 44(2): p. 192–201.
Kelsey, N.A., H.M. Wilkins, and D.A. Linseman, Nutraceutical antioxidants as novel neuroprotective agents. Molecules, 2010. 15(11): p. 7792–7814.
Brookmeyer, R., et al., Forecasting the global burden of Alzheimer’s disease. Alzheimer’s & dementia, 2007. 3(3): p. 186–191.
Becker, R.E. and N.H. Greig, Alzheimer’s disease drug development in 2008 and beyond: problems and opportunities. Current Alzheimer Research, 2008. 5(4): p. 346–357.
Schneider, L.S. and D.K. Lahiri, The perils of Alzheimer’s drug development. Current Alzheimer Research, 2009. 6(1): p. 77–78.
Cole, G.M., Q.-L. Ma, and S.A. Frautschy, Omega-3 fatty acids and dementia. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009. 81(2): p. 213–221.
Calon, F. and G. Cole, Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2007. 77(5): p. 287–293.
Zhang, W., et al., Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection. Frontiers in bioscience (Landmark edition), 2010. 16: p. 2653–2670.
Ng, T.-P., et al., Tea consumption and cognitive impairment and decline in older Chinese adults. The American journal of clinical nutrition, 2008. 88(1): p. 224–231.
Kuriyama, S., et al., Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project. The American journal of clinical nutrition, 2006. 83(2): p. 355–361.
Schaefer, E.J., et al., Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Archives of neurology, 2006. 63(11): p. 1545–1550.
Morris, M.C., et al., Fish consumption and cognitive decline with age in a large community study. Archives of neurology, 2005. 62(12): p. 1849–1853.
van Gelder, B.M., et al., Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. The American journal of clinical nutrition, 2007. 85(4): p. 1142–1147.
He, K., et al., Fish consumption and risk of stroke in men. Jama, 2002. 288(24): p. 3130–3136.
Arab, L., W. Liu, and D. Elashoff, Green and black tea consumption and risk of stroke. Stroke, 2009. 40(5): p. 1786–1792.
Kokubo, Y., et al., The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population. Stroke, 2013. 44(5): p. 1369–1374.
Noguchi-Shinohara, M., et al., Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PLoS One, 2014. 9(5): p. e96013.
Petursdottir, A.L., et al., Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2008. 63(11): p. 1153–1160.
Ehrnhoefer, D.E., et al., Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington’s disease models. Human molecular genetics, 2006. 15(18): p. 2743–2751.
Bastianetto, S., et al., Neuroprotective effects of green and black teas and their catechin gallate esters against β-amyloid-induced toxicity. European Journal of Neuroscience, 2006. 23(1): p. 55–64.
Zhang, G., et al., Panax ginseng ginsenoside-Rg 2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. Journal of ethnopharmacology, 2008. 115(3): p. 441–448.
Eckert, G.P., Traditional used plants against cognitive decline and Alzheimer disease. Frontiers in pharmacology, 2010. 1: p.138.
Heo, J.H., et al., An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease. European Journal of Neurology, 2008. 15(8): p. 865–868.
Ahmed, T., et al., Ginsenoside Rb1 as a neuroprotective agent: A review. Brain research bulletin, 2016. 125: p. 30–43.
Yurko-Mauro, K., et al., Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer’s & Dementia, 2010. 6(6): p. 456–464.
Bauer, I., et al., Omega-3 supplementation improves cognition and modifies brain activation in young adults. Human Psychopharmacology: Clinical and Experimental, 2014. 29(2): p. 133–144.
Boespflug, E., et al., Fish oil supplementation increases event-related posterior cingulate activation in older adults with subjective memory impairment. The journal of nutrition, health & aging, 2016. 20(2): p.161.
Feng, L., et al., Tea Consumption Reduces the Incidence of Neurocognitive Disorders: Findings from the Singapore Longitudinal Aging Study. J Nutr Health Aging, 2016. 20(10): p. 1002–1009.
Pan, C.-W., et al., Tea consumption and health-related quality of life in older adults. The journal of nutrition, health & aging, 2017. 21(5): p. 480–486.
Park, S.-K., et al., A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebocontrolled study. Journal of medicinal food, 2011. 14(4): p. 334–343.
Schmidt, A., et al., Green tea extract enhances parieto-frontal connectivity during working memory processing. Psychopharmacology, 2014. 231(19): p. 3879–3888.
Geng, J., et al., Ginseng for cognition. The Cochrane Library, 2010.
Shergis, J.L., et al., Panax ginseng in randomised controlled trials: a systematic review. Phytotherapy Research, 2013. 27(7): p. 949–965.
Lee, M.S., et al., Ginseng for cognitive function in Alzheimer’s disease: a systematic review. Journal of Alzheimer’s Disease, 2009. 18(2): p. 339–344.
Fotuhi, M., P. Mohassel, and K. Yaffe, Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nature Clinical Practice Neurology, 2009. 5(3): p. 140–152.
Dangour, A.D., et al., Omega 3 fatty acids and cognitive health in older people. British Journal of Nutrition, 2012. 107(S2): p. S152–S158.
Bos, D.J., et al., Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: What is the evidence? European Neuropsychopharmacology, 2016. 26(3): p. 546–561.
Bolling, B.W., C.-Y.O. Chen, and J.B. Blumberg, Tea and health: preventive and therapeutic usefulness in the elderly? Current opinion in clinical nutrition and metabolic care, 2009. 12(1): p.42.
Feng, L., et al., Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats. Archives of pharmacal research, 2010. 33(12): p. 1975–1984.
Stough, C., et al., Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. The The International Journal of Neuropsychopharmacology, 2001. 4(2): p. 131–134.
Akhondzadeh, S., et al., Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. Journal of clinical pharmacy and therapeutics, 2001. 26(5): p. 363–367.
Bourin, M., et al., A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundamental & clinical pharmacology, 1997. 11(2): p. 127–132.
Malsch, U. and M. Kieser, Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Psychopharmacology, 2001. 157(3): p. 277–283.
Connor, K. and J. Davidson, A placebo-controlled study of Kava kava in generalized anxiety disorder. International clinical psychopharmacology, 2002. 17(4): p. 185–188.
Gastpar, M. and H. Klimm, Treatment of anxiety, tension and restlessness states with Kava special extract WS® 1490 in general practice: A randomized placebo-controlled double-blind multicenter trial. Phytomedicine, 2003. 10(8): p. 631–639.
Jacobs, B.P., et al., An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine, 2005. 84(4): p. 197–207.
Sarris, J., et al., The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology, 2009. 205(3): p. 399–407.
Sarris, J., et al., St. John’s wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial. Human Psychopharmacology: Clinical and Experimental, 2009. 24(1): p. 41–48.
File, S.E., et al., Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause, 2005. 12(2): p. 193–201.
Elsabagh, S., D.E. Hartley, and S.E. File, Limited cognitive benefits in Stage+ 2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba. Journal of Psychopharmacology, 2005. 19(2): p. 173–181.
Cao, J., et al., Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clinical chemistry, 2006. 52(12): p. 2265–2272.
Fung, S.-T., et al., Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis). British Journal of Nutrition, 2013. 109(12): p. 2199–2207.
Reay, J.L., A.B. Scholey, and D.O. Kennedy, Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Human Psychopharmacology: Clinical and Experimental, 2010. 25(6): p. 462–471.
Folstein, M.F., S.E. Folstein, and P.R. McHugh, «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975. 12(3): p. 189–98.
Wechsler, D., WAIS-R manual: Wechsler adult intelligence scale-revised. 1981: Psychological Corporation.
Lamers, M.J., A. Roelofs, and I.M. Rabeling-Keus, Selective attention and response set in the Stroop task. Memory & Cognition, 2010. 38(7): p. 893–904.
Lezak, M.D., Neuropsychological assessment. 2004: Oxford University Press, USA.
Glover, G.H., T.Q. Li, and D. Ress, Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magnetic Resonance in Medicine, 2000. 44(1): p. 162–167.
Gold, B.T., et al., Lifelong bilingualism maintains neural efficiency for cognitive control in aging. Journal of Neuroscience, 2013. 33(2): p. 387–396.
Hakun, J.G., et al., Evidence for reduced efficiency and successful compensation in older adults during task switching. Cortex, 2015. 64: p. 352–62.
Sohn, M.-H., et al., The role of prefrontal cortex and posterior parietal cortex in task switching. Proceedings of the National Academy of Sciences, 2000. 97(24): p. 13448–13453.
Dreher, J.-C., et al., The roles of timing and task order during task switching. Neuroimage, 2002. 17(1): p. 95–109.
Pearson, J.M., et al., Posterior cingulate cortex: adapting behavior to a changing world. Trends in cognitive sciences, 2011. 15(4): p. 143–151.
Yeung, N., et al., Between-task competition and cognitive control in task switching. Journal of Neuroscience, 2006. 26(5): p. 1429–1438.
Luft, A.R., et al., Repetitive bilateral arm training and motor cortex activation in chronic stroke: a randomized controlled trial. Jama, 2004. 292(15): p. 1853–1861.
Chiaravalloti, N.D., et al., Increased cerebral activation after behavioral treatment for memory deficits in MS. Journal of neurology, 2012. 259(7): p. 1337–1346.
Rushworth, M., et al., Role of the human medial frontal cortex in task switching: a combined fMRI and TMS study. Journal of neurophysiology, 2002. 87(5): p. 2577–2592.
Rissman, J., A. Gazzaley, and M. D’Esposito, Measuring functional connectivity during distinct stages of a cognitive task. Neuroimage, 2004. 23(2): p. 752–63.
Biswal, B.B., et al., Toward discovery science of human brain function. Proc Natl Acad Sci U S A, 2010. 107(10): p. 4734–9.
Fox, M.D., et al., The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proceedings of the National Academy of Sciences of the United States of America, 2005. 102(27): p. 9673–9678.
Sridharan, D., D.J. Levitin, and V. Menon, A critical role for the right frontoinsular cortex in switching between central-executive and default-mode networks. Proceedings of the National Academy of Sciences, 2008. 105(34): p. 12569–12574.
Goulden, N., et al., The salience network is responsible for switching between the default mode network and the central executive network: replication from DCM. Neuroimage, 2014. 99: p. 180–190.
Greicius, M., Resting-state functional connectivity in neuropsychiatric disorders. Current Opinion in Neurology, 2008. 21(4): p. 424–430.
Greicius, M.D., et al., Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A, 2004. 101(13): p. 4637–42.
He, J., et al., Influence of functional connectivity and structural MRI measures on episodic memory. Neurobiol Aging, 2012. 33(11): p. 2612–2620.
Seeley, W.W., et al., Neurodegenerative diseases target large-scale human brain networks. Neuron, 2009. 62(1): p. 42–52.
Daniels, J.K., et al., Switching between executive and default mode networks in posttraumatic stress disorder: alterations in functional connectivity. Journal of psychiatry & neuroscience: JPN, 2010. 35(4): p.258.
Whitfield-Gabrieli, S. and J.M. Ford, Default mode network activity and connectivity in psychopathology. Annual review of clinical psychology, 2012. 8: p. 49–76.
Utevsky, A.V., D.V. Smith, and S.A. Huettel, Precuneus is a functional core of the default-mode network. Journal of Neuroscience, 2014. 34(3): p. 932–940.
Tsukada, H., et al., Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Brain research, 2000. 862(1): p. 180–186.
Wurtman, R.J., Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism, 2008. 57: p. S6–S10.
Tassoni, D., et al., The role of eicosanoids in the brain. Asia Pacific journal of clinical nutrition, 2008. 17(S1): p. 220–228.
Dyall, S.C., Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in aging neuroscience, 2015.7.
Mandel, S. and M.B. Youdim, Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radical Biology and Medicine, 2004. 37(3): p. 304–317.
Mandel, S.A., et al., Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS neuroscience & therapeutics, 2008. 14(4): p. 352–365.
Radad, K., R. Moldzio, and W.D. Rausch, Ginsenosides and their CNS targets. CNS neuroscience & therapeutics, 2011. 17(6): p. 761–768.
Kim, H.J., P. Kim, and C.Y. Shin, A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. Journal of ginseng research, 2013. 37(1): p.8.
Sperling, R.A., et al., Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 2011. 7(3): p. 280–292.
Jack, C.R., et al., Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. The Lancet Neurology, 2013. 12(2): p. 207–216.
Villemagne, V.L., et al., Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. The Lancet Neurology, 2013. 12(4): p. 357–367.
Eklund, A., T.E. Nichols, and H. Knutsson, Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates. Proceedings of the National Academy of Sciences of the United States of America, 2016. 113(28): p. 7900–7905.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carmichael, O.T., Pillai, S., Shankapal, P. et al. A Combination of Essential Fatty Acids, Panax Ginseng Extract, and Green Tea Catechins Modifies Brain fMRI Signals in Healthy Older Adults. J Nutr Health Aging 22, 837–846 (2018). https://doi.org/10.1007/s12603-018-1028-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-018-1028-2